Since the early 1970s, fenbendazole has been in circulation as a treatment for parasitic worm infect... View MoreSince the early 1970s, fenbendazole has been in circulation as a treatment for parasitic worm infections in dogs.In recent years, however, numerous publications and peer-reviewed case reports have demonstrated that fenbendazole is also highly effective in the treatment of certain aggressive cancers in humans. It is believed that this is due to the following characteristics that distinguish fenbendazole from other cancer treatmentsAs stated previously, a significant number of scientific publications support and validate its efficacy in treating certain aggressive cancers in humans.E.g. It has been reported that Fenbendazole alone is an effective treatment for patients with diffuse large B-cell lymphoma, metastatic cancer, renal cell carcinoma, and bladder cancer.Fenbendazole has minimal adverse effects and is extremely safe for human use.It is available without a prescription in many nations.Extremely inexpensive to manufacture.In addition, in our article How does fenbendazole work We reported that the anticancer action of fenbendazole is very similar to the group of plant alkaloid chemotherapies to which Taxol belongs. In addition, fenbendazole's toxicity levels are significantly lower than those of conventional chemotherapies due to its unique mode of action and exceptional safety profile.Through numerous observations and discoveries, it has become evident (due to the emergence of certain patterns) that the origin of some cancers may be related to and triggered by viruses, parasites, and other such agents.In fact, it is possible that this is the case in many more instances than we are aware of, particularly if cancer cells find themselves in fertile ground, which is characterized by compromised immunity and specific genetic predilections.As a result, we give serious consideration to the use of anti-parasitic, anti-worm, anti-lactate, and other drugs as part of a comprehensive cancer treatment strategy that may also involve conventional cancer therapies.Fenbendazole for humansLike mebendazole, fenbendazole is not a drug that is commonly used to treat humans. Fenbendazole is typically administered to animals (including mammals, birds, and fish) with parasites, as it is known to kill a variety of parasitic worms, including whipworm, hookworm, certain tapeworms, and roundworm.Years ago, our own research brought fenbendazole to our attention in relation to the treatment of cancer under brand names such as Panacur or Safe-Guard. However, the renowned story of a man who successfully treated his small cell lung cancer with the anti-worm drug has rekindled our interest in the disease.Since then, a dedicated website and a Facebook group have served as platforms to chronicle his own experience, as well as the experience of other patients who are experiencing the benefits of using Fenbendazole in the treatment of cancers such as non-small cell lung cancer, melanoma, colorectal cancer, prostate cancer, stage four pancreatic cancer, and others.The cancer-fighting potential of numerous benzimidazole-class drugs is supported by a growing body of scientific evidence, which is bolstered by these recent studies. As a result, we are of the opinion and belief that, like mebendazole, fenbendazole for humans possesses significant anti-cancer potential.Several studies have demonstrated that fenbendazole is more effective than mebendazole. In one such study, fenbendazole was shown to be significantly more effective than mebendazole and other drugs in combating Cryptococcus neoformans – an opportunistic fungus that can be found anywhere in the world and may cause Cryptococcus meningitis in certain individuals.Moreover, of the numerous scientific articles that have been published and suggested that Fenbendazole has anti-cancer properties, this study determined that Fenbendazole acts as a moderate microtubule destabilizing agent and induces cancer cell death by modulating multiple cellular pathways.The results, in conjunction with our previous findings, suggest that Fenbendazole is a new microtubule interfering agent that exhibits anti-neoplastic activity and may be evaluated as a potential therapeutic agent due to its effect on multiple cellular pathways that result in the effective elimination of cancer cells.The authors of this study concluded that fenbendazole's cancer-fighting mechanisms disrupted not only the proteasomal interference and microtubule function of cancer cells, but also their glucose uptake, starving the cancer cells. Fenbendazole decreased glucose transporter isoform 4 expression (GLUT4). Insulin stimulates glucose uptake in cells by transporting GLUT4 from intracellular vesicles to the plasma membrane, where it can absorb glucose. By inhibiting GLUT4's linear movement through the microtubule with fenbendazole, insulin-stimulated sugar uptake is significantly reduced.Furthermore, because fenbendazole functions similarly to colchicine (by interacting with a site on tubulin) but is distinct from other vinca alkaloids and other chemotherapies, it will not compete with them. As with other benzimidazole compounds, fenbendazole enhances the anti-cancer effects of other cancer treatments, such as surgery, radiotherapy, sodium dichloroacetate (DCA), berberine, etc.In addition, a recently published scientific paper suggests that fenbendazole (and similar drugs) have the potential to reactivate the p53 gene. As a tumor suppressor, p53 is referred to as the Guardian of the Genome. In certain cancers, however, its suppressive ability can be inhibited.In addition, the Nature article states that fenbendazole was extremely effective when combined with DCA.Fenbendazole for human consumption – is it suitable for human consumptionAlthough fenbendazole is typically prescribed for the treatment of parasitic worms in animals, according to a report from the European Medicines Agency, Fenbendazole appears to be well tolerated in humans following oral exposure (single oral dose up to 2,000 mgperson 500 mgperson for 10 consecutive days).However, long-term exposure is not yet supported by scientific evidence. This is likely due to the nature of the medication, as parasitic infections are typically eliminated within one to two weeks.Despite this, many individuals have taken fenbendazole daily for years as a prophylactic measure to prevent recurrence of cancer or as an active treatment against their tumors. The treatment appears to be safe and causes side effects infrequently, if ever.https://www.fenbendazole.org/2022/03/28/fenbendazole-for-humans/
About Me
Since the early 1970s, fenbendazole has been in circulation as a treatment for parasitic worm infect... View More